ID

44019

Description

SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00288379

Lien

https://clinicaltrials.gov/show/NCT00288379

Mots-clés

  1. 07/04/2016 07/04/2016 -
  2. 20/09/2021 20/09/2021 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Asthma NCT00288379

Eligibility Asthma NCT00288379

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00288379
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
a diagnosed history of asthma for at least 6 months
Description

asthma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0040223
mild and stable asthma, only using β2-agonists as needed for the last 4 weeks.
Description

mild stable asthma only using β2-agonists

Type de données

boolean

Alias
UMLS CUI [1,1]
C0741266
UMLS CUI [1,2]
C2945599
UMLS CUI [2]
C2936789
fev1 >70% of predicted normal value (post-bronchodilator value).
Description

fev1 post-bronchodilator

Type de données

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C2599594
skin prick test positive to pollen, animal dander or house dust mite.
Description

skin prick test positive to pollen, animal dander or house dust mite

Type de données

boolean

Alias
UMLS CUI [1,1]
C0430561
UMLS CUI [1,2]
C0323138
UMLS CUI [1,3]
C0440454
UMLS CUI [1,4]
C3539110
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any significant respiratory disease, other than asthma.
Description

respiratory disease

Type de données

boolean

Alias
UMLS CUI [1]
C0035204
upper or lower respiratory tract infection within 4 weeks before inclusion.
Description

respiratory tract infection

Type de données

boolean

Alias
UMLS CUI [1,1]
C0035243
UMLS CUI [1,2]
C0040223
use of:
Description

use of

Type de données

boolean

Alias
UMLS CUI [1]
C1524063
1. inhaled glucocorticosteroid treatment for the last 8 weeks prior to inclusion or ever used oral glucocorticoid treatment for asthma.
Description

inhaled steroid treatment

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0556393
UMLS CUI [1,3]
C0006280
UMLS CUI [1,4]
C0040223
2. inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes within 2 weeks of screening.
Description

inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes

Type de données

boolean

Alias
UMLS CUI [1]
C2936789
UMLS CUI [2]
C0354764
UMLS CUI [3]
C0019590
UMLS CUI [4]
C0039771
3. regular nsaids
Description

nsaids

Type de données

boolean

Alias
UMLS CUI [1]
C0003211

Similar models

Eligibility Asthma NCT00288379

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00288379
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
asthma
Item
a diagnosed history of asthma for at least 6 months
boolean
C0004096 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
mild stable asthma only using β2-agonists
Item
mild and stable asthma, only using β2-agonists as needed for the last 4 weeks.
boolean
C0741266 (UMLS CUI [1,1])
C2945599 (UMLS CUI [1,2])
C2936789 (UMLS CUI [2])
fev1 post-bronchodilator
Item
fev1 >70% of predicted normal value (post-bronchodilator value).
boolean
C0748133 (UMLS CUI [1,1])
C2599594 (UMLS CUI [1,2])
skin prick test positive to pollen, animal dander or house dust mite
Item
skin prick test positive to pollen, animal dander or house dust mite.
boolean
C0430561 (UMLS CUI [1,1])
C0323138 (UMLS CUI [1,2])
C0440454 (UMLS CUI [1,3])
C3539110 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
respiratory disease
Item
any significant respiratory disease, other than asthma.
boolean
C0035204 (UMLS CUI [1])
respiratory tract infection
Item
upper or lower respiratory tract infection within 4 weeks before inclusion.
boolean
C0035243 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
use of
Item
use of:
boolean
C1524063 (UMLS CUI [1])
inhaled steroid treatment
Item
1. inhaled glucocorticosteroid treatment for the last 8 weeks prior to inclusion or ever used oral glucocorticoid treatment for asthma.
boolean
C0001617 (UMLS CUI [1,1])
C0556393 (UMLS CUI [1,2])
C0006280 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes
Item
2. inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes within 2 weeks of screening.
boolean
C2936789 (UMLS CUI [1])
C0354764 (UMLS CUI [2])
C0019590 (UMLS CUI [3])
C0039771 (UMLS CUI [4])
nsaids
Item
3. regular nsaids
boolean
C0003211 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial